Interleukin-21 modulates Th1 and Th17 responses in giant cell arteritis-Reference-Cited by-同舟云学术

Interleukin-21 modulates Th1 and Th17 responses in giant cell arteritis

Published:2012-05-25 Issue:6 Volume:64 Page:2001-2011
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis & Rheumatism

Author:

Terrier Benjamin,Geri Guillaume,Chaara Wahiba,Allenbach Yves,Rosenzwajg Michelle,Costedoat-Chalumeau Nathalie,Fouret Pierre,Musset Lucile,Benveniste Olivier,Six Adrien,Klatzmann David,Saadoun David,Cacoub Patrice

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/art.34327/fullpdf

Reference17 articles.

1. Medium- and large-vessel vasculitis;Weyand;N Engl J Med,2003

2. Polymyalgia rheumatica and giant-cell arteritis;Salvarani;Lancet,2008

3. Permanent visual loss and cerebrovascular accidents in giant cell arteritis: predictors and response to treatment;Gonzalez-Gay;Arthritis Rheum,1998

4. The therapeutic impact of temporal artery biopsy;Hall;Lancet,1983

5. IRF-4-binding protein inhibits interleukin-17 and interleukin-21 production by controlling the activity of IRF-4 transcription factor;Chen;Immunity,2008

Cited by 146 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The pipeline of immunomodulatory therapies in polymyalgia rheumatica and giant cell arteritis: A systematic review of clinical trials;Autoimmunity Reviews;2024-07

2. Vascular disease persistence in giant cell arteritis: are stromal cells neglected?;Annals of the Rheumatic Diseases;2024-04-29

3. Neue Ansätze in der immunologischen Therapie der Riesenzellarteriitis und Polymyalgia rheumatica;Arthritis und Rheuma;2024-04

4. Predominance of T-bet-positive Th1 cells in infiltrating T-lymphocytes in most of active arteritis lesions of giant cell arteritis;Virchows Archiv;2024-03-13

5. Current Insights into Tissue Injury of Giant Cell Arteritis: From Acute Inflammatory Responses towards Inappropriate Tissue Remodeling;Cells;2024-02-29